{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:18:43Z","timestamp":1776086323501,"version":"3.50.1"},"reference-count":11,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatopathology"],"abstract":"<jats:p>Year after year, the incidence and prevalence rates of cutaneous Malignant Melanoma (MM) show a continuous increase and, according to the most up-to-date American Cancer Society (ACS) projections, it is estimated that 97,610 new melanomas will be diagnosed in 2023 (about 58,120 in men and 39,490 in women) and approximately 7990 people are expected to die of melanoma (about 5420 men and 2570 women) [...]<\/jats:p>","DOI":"10.3390\/dermatopathology10010013","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T03:09:32Z","timestamp":1676344172000},"page":"91-92","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Histopathological Diagnosis of Malignant Melanoma at the Dawn of 2023: Knowledge Gained and New Challenges"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-4316","authenticated-orcid":false,"given":"Gerardo","family":"Cazzato","sequence":"first","affiliation":[{"name":"Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"ref_1","unstructured":"(2023, January 25). Key Statistics for Melanoma Skin Cancer. Available online: https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/about\/key-statistics.html#:~:text=Overall%2C%20the%20lifetime%20risk%20of,Factors%20for%20Melanoma%20Skin%20Cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.det.2022.07.017","article-title":"Melanoma classification and management in the era of molecular medicine","volume":"41","author":"Rashid","year":"2023","journal-title":"Dermatol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/dermatopathology8020019","article-title":"The Great Mime: Three Cases of Melanoma with Carcinoid-Like and Paraganglioma-Like Pattern with Emphasis on Differential Diagnosis","volume":"8","author":"Cazzato","year":"2021","journal-title":"Dermatopathology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/cup.13648","article-title":"Immunohistochemistry utilization in the diagnosis of melanoma","volume":"47","author":"Dinehart","year":"2020","journal-title":"J. Cutan. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.5858\/arpa.2012-0284-OA","article-title":"Marginal and Joint Distributions of S100, HMB-45, and Melan-A Across a Large Series of Cutaneous Melanomas","volume":"137","author":"Viray","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gelmi, M.C., Houtzagers, L.E., Strub, T., Krossa, I., and Jager, M.J. (2022). MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116001"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2133.1999.03002.x","article-title":"Immunohistochemistry and sentinel node biopsy in melanoma: The use of tyrosinase and Melan-A","volume":"141","author":"Jarrett","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cazzato, G., Mangialardi, K., Falcicchio, G., Colagrande, A., Ingravallo, G., Arezzo, F., Giliberti, G., Trilli, I., Loizzi, V., and Lettini, T. (2022). Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study. Genes, 13.","DOI":"10.3390\/genes13030545"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Massi, G., and LeBoit, P. (2014). Histological Diagnosis of Nevi and Melanoma, Springer. [2nd ed.].","DOI":"10.1007\/978-3-642-37311-4"},{"key":"ref_10","unstructured":"Elder, D.E., Massi, D., Scolyer, R.A., and Willemze, R. (2018). WHO Classification of Skin Tumours, IARC. [4th ed.]."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"675296","DOI":"10.3389\/fonc.2021.675296","article-title":"The WHO 2018 Classification of Cutaneous Melanocytic Neoplasms: Suggestions from Routine Practice","volume":"11","author":"Ferrara","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2296-3529\/10\/1\/13\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:33:55Z","timestamp":1760121235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2296-3529\/10\/1\/13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["dermatopathology10010013"],"URL":"https:\/\/doi.org\/10.3390\/dermatopathology10010013","relation":{},"ISSN":["2296-3529"],"issn-type":[{"value":"2296-3529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]}}}